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Abstract:  Infections of diabetic ulcers may occur because patients with diabetes mellitus have 
a weak immune system and the presence of high blood sugar into a strategic place for bacterial 
growth one of them is Staphylococcus aureus. Increased resistance of Staphylococcus aureus 
to various antibiotics, causing problems for the treatment of this infection. As by Methicillin-
resistant Staphylococcus aureus (MRSA) This study aims to assess the presence of Staphylo-
coccus aureus and Methicillin-resistant Staphylococcus aureus (MRSA) at diabetic ulcer patient 
at Banjarmasin city hospital. This research uses descriptive observational research type. The 
study sample was patients with grade 2 and three diabetic ulcers with a total of 30 samples. 
The result of the research found 14 Staphylococcus aureus bacteria, Staphylococcus epider-
midis nine, Staphylococcus saprophyticus two and 5 Gram-negative bacteria. Of the 14 sam-
ples of Staphylococcus aureus, there were eight samples of cefoxitin-resistant samples. The 
conclusion was 47% of Staphylococcus aureus in patients with a diabetic ulcer at Banjarmasin 
City Hospital. There was a 57% Methicillin-resistant Staphylococcus aureus in the isolated 
Staphylococcus aureus found. Need further research on the resistance of antibiotics oxacillin 
and cefoxitin to other Staphylococcus sp bacteria derived from patient diabetic ulcers.  
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INTRODUCTION 
Indonesia is a tropical country, where 
an infection is still the disease and the number 
one cause of death. Infection can occur in pa-
tients with diabetes mellitus who have open 
wounds or on diabetic ulcers. The prevalence 
of diabetic ulcer patients in Indonesia is about 
15% with a mortality rate of 32%, as well as 
the cause of hospital treatment with the most 
80% for diabetes mellitus (Pendsey, 2010). 
Infection can occur because diabetes 
mellitus patients have a weak immune system 
and high blood sugar to be a strategic place 
for bacterial growth one of them is Staphylo-
coccus aureus (Hastuti, 2008). The results of 
Akhi et al. (2015), stated that the infection in 
diabetic ulcer sufferers caused by polymicrobi-
al consisting of aerobic bacteria one of them is 
Staphylococcus aureus (28%). 
Staphylococcus aureus in the hospital 
may contaminate the surrounding environment 
including medical devices such as stetho-
scopes (Lutpiatina, L., 2017) and possibly in-
fect patients. Hospital-staphylococcus aureus 
may be resistant to some antibiotics, but more 
sensitive to natural ingredients such as bee 
propolis (Lutpiatina, L., 2015) and leaf kenikir 
(Cosmos caudatus Kunth.) (Lutpiatina, L., Nur 
Rizqi Amaliah, Ratih Dewi Dwiyanti, 2017). 
The abundance of irrational antibiotics 
is one of the main factors of antibiotic re-
sistance (Sun et al., 2011). People infected 
with antibiotic-resistant microorganisms are a 
more frequent hospital and require treatment 
with second or third-choice drugs that may be 
less effective, more toxic and costly. Is further 
exacerbated by data showing that approxi-
mately 23,000 people die each year due to the 
bacterial infection that has been resistant to 
antibiotics (Sun et al., 2011). 
The prevalence of antibiotic resistance 
increases every year. Based on a survey con-
ducted by the Centers for Disease Control and 
Prevention (CDC) in 2013 in the United States, 
every year at least 2 million people are ex-
posed to bacterial infections that are resistant 
to one or more types of antibiotics.  
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Based on World Health Organization (WHO) 
data in 2009, Indonesia ranks 8th out of 27 
countries with high burden of antibiotic re-
sistance to Multi-Drug Resistance (MDR) bac-
teria in the world. 
 Staphylococcus aureus strains that 
have been resistant to antibiotic activity are 
among the β-lactam groups, including the pen-
icillinase-resistant penicillins (oxacillin, methi-
cillin, nepheline, cloxacillin, dicloxacillin), ceph-
alosporins, and carbapenem groups (Yuwono, 
2012). Result of Mutia (2010) research at Ulin 
Banjarmasin Hospital, found the resistance of 
Staphylococcus aureus bacteria to cephalo-
sporin group antibiotic. The results of Meta et 
al. (2014) found bacteria Methicillin-resistant 
Staphylococcus aureus (MRSA) from diabetic 
ulcers of degree I and II in the disease in 
RSUD Arifin Achmad as many as five samples 
(83.33%). 
 It known that the resistance of Staphylo-
coccus aureus to cephalosporin, cephalexin 
and cefotaxime antibiotics based on Mutia 
(2010) study at Banjarmasin City Hospital, but 
in CLSI standard (2017) stated that used as 
the standard test of β-lactam resistance group 
are oxacillin and cefoxitin. Both of these antibi-
otics are also the basis for the identification of 
methicillin-resistant Staphylococcus aureus 
(MRSA) bacteria, so it is to research the re-
sistance of Staphylococcus aureus derived 
from diabetic ulcers against β-lactam group 
antibiotics using oxacillin and cefoxitin discs. 
The purpose of this study was to assess the 
presence of Staphylococcus aureus and 
Methicillin-resistant Staphylococcus aureus 
(MRSA) in patients with diabetic ulcers in Ban-
jarmasin city hospitals. 
 
MATERIALS AND METHODS 
 The type of research used in this re-
search is descriptive observational. The sam-
ple of the study was diabetes mellitus patients 
who had body wounds or diabetic ulcers who 
examined in Banjarmasin city hospital. Sam-
pling technique by purposive sampling that is 
wound swab patient of diabetes mellitus grade 
2 and 3. 
 Isolation and identification of Staphylo-
coccus aureus bacteria have taken from pa-
tients' diabetic ulcer swabs by planting on agar 
and Mannitol Salt Agar agar medium (Merck). 
Staphylococcus aureus has fermented manni-
tol to form a yellow colony and change the col-
or of the media to yellow. Gram stain has been 
performing on colonies grown on Mannitol Salt 
Agar medium; Staphylococcus aureus is a pur-
ple gram-positive (+) bacteria with a clustered 
shaped form like grapes. A biochemical test of 
the confectionary medium has been perform-
ing, Staphylococcus aureus fermenting glu-
cose and mannitol. Staphylococcus aureus 
positive (+) catalase test. Coagulase Staphylo-
coccus aureus positive (+) test. 
 Antibiotic resistance test using Kirby 
and Bauer method using Mueller Hinton 
(Merck) medium with 10 μg oxacillin disc and 
30 μg cefoxitin (Clinical Laboratory Standards 
Institute(CLSI), 2017). 
 
RESULTS AND DISCUSSION 
 This study conducted on 30 patients 
with type II diabetes mellitus who perform ex-
amination and treatment of wounds in Diabetic 
Foot Poly. Characteristics of respondents can 
be seen in table 1 as follows. 
 
















The result of bacteria identification on 
diabetic ulcus samples found 14 Staphylococ-
cus aureus bacteria, Staphylococcus epider-
midis of 9, Staphylococcus saprophyticus as 
much as two, and Gram-negative bacteria of 5 








Chart 1. Result of Bacterial Identification on 
Sample of Diabetic Ulcer 
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Table 2. Results of Resistance Examination 
on Staphylococcus aureus Isolates from  
























 Chart 1 shows 47% of Staphylococcus 
aureus. What the high infection of diabetic 
wounds caused by Staphylococcus aureus 
bacteria can cause by this bacteria is flora of 
the skin, so if an open wound will become the 
entrance of bacteria and can cause infection if 
it can not control. Staphylococcus aureus can 
produce β lactamase, which will hydrolyze the 
bonds on the antibiotic-lactam molecule β-
lactam ring and result in antimicrobial inactiva-
tion resulting in resistance to antibiotics 
(Pratiwi, 2008). Infection caused by Staphylo-
coccus aureus could be more if it caused by 
an antimicrobial-resistant strain (Monecke, 
2011). 
 Incidence of resistance to diabetic 
wounds may have an effect on length of hospi-
talization, affecting morbidity and mortality 
(Radji et al., 2014). MRSA from hospitals and 
other external environments is a concern for 
public health (Gould S. W. J. 2010, Deuren-
berg R. H. 2007) 
 Table 2 shows the results of cefoxitin 
resistance as much as 57%. Indicates that 
there is a 57% MRSA in Staphylococcus aure-
us isolates found in this study. Clinical Labora-
tory Standards Institute (CLSI) in 2017 states 
to detect MRSA using cefoxitin. The results of 
diffusion of cefoxitin discs (resistant ≤21mm, 
sensitive ± 22mm) can be used to predict the 
presence of Staphylococcus aureus with the 
MecA gene, whereas for oxacillin it is not rec-
ommended to use disc diffusion results but 
can use minimal inhibitory concentrations 
(MIC). This study used the disc diffusion meth-
od for both antibiotics, so the oxacillin inhibito-
ry results were not seen by CLSI recommen-
dations 2017. Other studies also suggest that 
cefoxitin disc diffusion assays are recommend-
ed for MRSA routine detection and are consid-
ered a better indicator of oxacillin (Ibrahim, O. 
M. A., Bilal, N. E., Osman, O. F., & Magzoub, 
M. A.2017, RW Smyth 2005, Mimica MJ., 
2007). 
 Similar studies conducted by Adhikari 
R. et al. (2017) were on wound swabs with a 
yield of 15.47% found in Staphylococcus aure-
us, of which 39 (35.50%) isolates were identi-
fied as MRSA by disc diffusion method of 
cefoxitin. According to Baddour M. M (2006), 
Koyama N. (2012), Rehm S. J. (2008), Torimi-
ro N (2013) MRSA is resistant to all β-lactam 
classes including cephalosporins and car-
bapenems. MRSA resistance may develop in 
quinolones, aminoglycosides, and higher mac-
rolides. 
 MRSA formed by the presence of mecA 
gene, a meticillin-resistant encoding found in 
Staphylococcus aureus. This resistant gene 
encodes Penicillin Binding Protein 2a (PBP 2a) 
which does not bind meticillin as it should. (Ito 
T., 2001, Grundmann H. 2006). MRSA infec-
tions require relatively more difficult, and high-
er maintenance, so accurate and rapid MRSA 
identification is essential (Johnson A. P. 2011). 
 
CONCLUSION 
 There is 47% of Staphylococcus aureus 
in patients with the diabetic ulcer in Banjarma-
sin City Hospital. There was a 57% Methicillin-
resistant Staphylococcus aureus in the isolat-
ed Staphylococcus aureus found. 
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